Detalles de la búsqueda
1.
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.
Clin Infect Dis
; 71(11): 2777-2786, 2020 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31793991
2.
Assessment of Drug Resistance during Phase 2b Clinical Trials of Presatovir in Adults Naturally Infected with Respiratory Syncytial Virus.
Antimicrob Agents Chemother
; 64(9)2020 08 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32071058
3.
High blood eosinophil count is associated with more frequent asthma attacks in asthma patients.
Ann Allergy Asthma Immunol
; 113(1): 19-24, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24846699
4.
Clinical trial simulation to assist in COPD trial planning and design with a biomarker-based diagnostic: when to pull the trigger?
COPD
; 11(2): 226-35, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24111823
5.
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia.
J Allergy Clin Immunol
; 132(5): 1086-1096.e5, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23866823
6.
Discriminating sputum-eosinophilic asthma: Accuracy of cutoffs in blood eosinophil measurements versus a composite index, ELEN.
J Allergy Clin Immunol
; 136(3): 812-814.e2, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25913197
7.
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma.
J Allergy Clin Immunol
; 125(6): 1237-1244.e2, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20513521
8.
MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function.
J Allergy Clin Immunol
; 125(6): 1344-1353.e2, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20513525
9.
Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis.
Clin Ther
; 40(1): 156-165.e5, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29287749
10.
Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.
PLoS One
; 13(5): e0197474, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29758082
11.
High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
J Allergy Clin Immunol Pract
; 2(6): 741-50, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25439366
12.
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.
Lancet Respir Med
; 2(11): 879-890, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25306557
13.
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.
Lancet Respir Med
; 2(9): 738-49, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25154045
14.
The association of blood eosinophil counts to future asthma exacerbations in children with persistent asthma.
J Allergy Clin Immunol Pract
; 3(2): 283-287.e4, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25609347
Resultados
1 -
14
de 14
1
Próxima >
>>